The MISTIGRI thermal infrared project: scientific objectives and mission specifications

This article presents the MISTIGRI project of a microsatellite developed by the French space agency Centre National d'Etudes Spatiales (CNES) in cooperation with Spain (Image Processing Laboratory of the University of Valencia and Centro para el Desarrollo Tecnológico Industrial (CDTI)). MISTIGRI is a mission that has the originality of combining a high spatial resolution (～50 m) with a daily revisit in the thermal infrared (TIR). MISTIGRI is an experimental mission devoted to demonstrate the potential of such TIR data for future operational missions. The scientific goals and expected applications of the mission are described: they encompass the monitoring of (i) agricultural areas and related hydrological processes, (ii) urban areas, and (iii) coastal areas and continental waters. Then, the specifications on spatial resolution, revisit frequency, overpass time, and spectral configuration are justified. The strategy of the mission is based on the combination with a network of long-term experimental sites. It will also make possible observing some areas facing rapid climatic change. The choice of the orbit is presented. Finally, we give rapid overviews of both the instrumental concept and the proposed mission architecture.     

Purification, crystallisation and preliminary X-ray diffraction study of ribosome inactivating protein: saporin

OBJECTIVES: To compare transesophageal atrial pacing stress echocardiography with dobutamine stress echocardiography for feasibility, safety, duration, patient acceptance and concordance in inducing wall motion abnormalities. BACKGROUND: Transesophageal atrial pacing is an effective method of increasing heart rate and has been used in the assessment of coronary artery disease. METHODS: Both tests were performed in sequence on the same patients in random order. Transesophageal atrial pacing stress echocardiography began at a heart rate of 10 beats/min above the baseline value and was increased by 20 beats/min every two min until 85% of the age-predicted maximum heart rate or another end point was reached. Dobutamine echocardiography was performed using three-min stages and a maximum dose of 40 microg/kg per min. Atropine (total dose < or =2 mg) was administered at the start of the 40 microg/kg per min stage if needed to augment heart rate or during pacing if Wenckebach heart block occurred. RESULTS: Transesophageal atrial pacing stress echocardiography was feasible in 100 of 104 patients (96%); the duration (8.6+/-3.6 min) was significantly shorter than that of dobutamine stress echocardiography (15.1+/-3.9 min) (p = 0.0001). With transesophageal atrial pacing stress echocardiography, the recovery period was shorter, symptoms and dysrhythmias were fewer, hypertension and hypotension were less common and target heart rate was more frequently achieved. No complications occurred with either test. Patient acceptance was satisfactory. Agreement between results of both tests was good for segmental wall motion scoring with a 16-segment model, scores 1 to 5 (kappa: rest, 0.79; peak, 0.57) and test interpretation (normal, ischemia, infarction or resting wall motion abnormality with ischemia) (kappa: 0.77). CONCLUSIONS: Transesophageal atrial pacing stress echocardiography is a feasible, well-tolerated alternative to dobutamine stress echocardiography. It can be performed rapidly and shows good agreement with dobutamine stress echocardiography in the induction of myocardial ischemia.